Last 12 months
Inside the activity.
0 purchase rows · 114 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 20 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 23 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2023 Filed Apr 6, 2023 01:30 UTC |
Oren IlanDirector
|
GrantCommon Shares | 1,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-016867 · form4.xml · nonDerivative · entry 1 Oren Ilan · CIK 0001643073 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,113 F1 · shares: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. F1 · price: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. Read SEC document |
| April 03, 2023 Filed Apr 6, 2023 01:31 UTC |
MOMTAZEE JAMES CDirector
|
GrantCommon Shares | 1,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-016868 · form4.xml · nonDerivative · entry 1 MOMTAZEE JAMES C · CIK 0001209181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,125 F1 · shares: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. F1 · price: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. Read SEC document |
| March 29, 2023 Filed Apr 1, 2023 01:30 UTC | OtherCommon Shares | 1,639 | $7.35 | $12,046.65 |
DisclosureSEC source: 0001140361-23-015526 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,708 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. Read SEC document |
|
| March 23, 2023 Filed Mar 28, 2023 01:30 UTC |
Venker EricPresident & COO
|
OtherCommon Shares | 14,194 | $7.30 | $103,616.20 |
DisclosureSEC source: 0001140361-23-014076 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 690,225 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| March 23, 2023 Filed Mar 28, 2023 01:30 UTC |
Kumar RakhiChief Accounting Officer
|
OtherCommon Shares | 2,134 | $7.30 | $15,578.20 |
DisclosureSEC source: 0001140361-23-014075 · form4.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,409 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| March 23, 2023 Filed Mar 28, 2023 01:30 UTC |
Gline MatthewDirector · CEO
|
OtherCommon Shares | 18,563 | $7.30 | $135,509.90 |
DisclosureSEC source: 0001140361-23-014077 · form4.xml · nonDerivative · entry 1 Gline Matthew · CIK 0001750094 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,600 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| March 20, 2023 Filed Mar 23, 2023 01:00 UTC |
SVF Investments (UK) Ltd10% owner
SoftBank Vision Fund L.P.10% owner
SVF Holdings (UK) LLP10% owner
SB INVESTMENT ADVISERS (UK) LTD10% owner
|
SaleCommon Shares | 12,000,000 | $8.00 | $96,000,000.00 |
DisclosureSEC source: 0000899243-23-009465 · doc4.xml · nonDerivative · entry 1 SVF Investments (UK) Ltd · CIK 0001716729 · 10% owner SoftBank Vision Fund L.P. · CIK 0001699940 · 10% owner SVF Holdings (UK) LLP · CIK 0001716727 · 10% owner SB INVESTMENT ADVISERS (UK) LTD · CIK 0001731509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 83,031,667 F1 · ownership.nature: Securities held of record by SVF Investments (UK) Limited ("SVF Investments"). Softbank Vision Fund L.P. is the managing member of SVF Holdings (UK) LLP, which is the sole owner of SVF Investments. SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as the alternative investment fund manager ("AIFM") of SoftBank Vision Fund L.P. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund L.P.'s investments. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:00 UTC | SaleCommon Shares | 1,912 | $8.08 | $15,448.96 |
DisclosureSEC source: 0001140361-23-010166 · form4.xml · nonDerivative · entry 1 Pulik Richard · CIK 0001885841 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,347 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · balance_after: Includes Common Shares purchased under the Company's Employee Stock Purchase Plan. Read SEC document |
|
| February 22, 2023 Filed Feb 22, 2023 22:04 UTC |
Ramaswamy VivekDirector
|
SaleCommon Shares | 4,000,000 | $7.95 | $31,800,000.00 |
DisclosureSEC source: 0001140361-23-008049 · form4.xml · nonDerivative · entry 1 Ramaswamy Vivek · CIK 0001635075 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,409,211 F1 · shares: The reporting person does not expect to sell additional shares of the Issuer for the foreseeable future. F2 · balance_after: Reflects an award of restricted stock covering Common Shares that is fully vested. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:30 UTC |
Venker EricPresident & COO
|
OtherCommon Shares | 11,953 | $8.43 | $100,763.79 |
DisclosureSEC source: 0001140361-23-008667 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,419 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:30 UTC |
Kumar RakhiChief Accounting Officer
|
OtherCommon Shares | 1,797 | $8.43 | $15,148.71 |
DisclosureSEC source: 0001140361-23-008668 · form4.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,543 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:30 UTC |
Gline MatthewDirector · CEO
|
OtherCommon Shares | 14,471 | $8.43 | $121,990.53 |
DisclosureSEC source: 0001140361-23-008666 · form4.xml · nonDerivative · entry 1 Gline Matthew · CIK 0001750094 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,163 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4 Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 02:01 UTC |
Venker EricPresident & COO
|
OtherCommon Shares | 13,057 | $8.56 | $111,767.92 |
DisclosureSEC source: 0001140361-23-002961 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,372 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 02:01 UTC |
Gline MatthewDirector · CEO
|
OtherCommon Shares | 15,594 | $8.56 | $133,484.64 |
DisclosureSEC source: 0001140361-23-002960 · form4.xml · nonDerivative · entry 1 Gline Matthew · CIK 0001750094 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109,634 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4 Read SEC document |
| January 24, 2023 Filed Jan 27, 2023 02:01 UTC |
Kumar RakhiChief Accounting Officer
|
OtherCommon Shares | 1,838 | $8.56 | $15,733.28 |
DisclosureSEC source: 0001140361-23-002959 · form4.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,340 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| January 05, 2023 Filed Jan 7, 2023 02:30 UTC |
Venker EricPresident & COO
|
SaleCommon Shares | 24,037 | $8.02 | $192,776.74 |
DisclosureSEC source: 0001140361-23-000876 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,429 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 02:30 UTC |
Venker EricPresident & COO
|
SaleCommon Shares | 95,484 | $7.32 | $698,942.88 |
DisclosureSEC source: 0001140361-23-000545 · form4.xml · nonDerivative · entry 2 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 753,466 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022. F2 · balance_after: A Form 4 filed by the reporting person on December 28, 2022 inadvertently overstated the total number of Common Shares held by the reporting person by 28,936 Common Shares. The updated amounts reported here correct that error and reflect the reporting person's holdings. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:30 UTC |
MOMTAZEE JAMES CDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-000728 · form4.xml · nonDerivative · entry 1 MOMTAZEE JAMES C · CIK 0001209181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,774 F1 · shares: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. F1 · price: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:30 UTC |
Oren IlanDirector
|
GrantCommon Shares | 2,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-000729 · form4.xml · nonDerivative · entry 1 Oren Ilan · CIK 0001643073 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,171 F1 · shares: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. F1 · price: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. Read SEC document |
| December 30, 2022 Filed Jan 5, 2023 02:30 UTC |
Venker EricPresident & COO
|
SaleCommon Shares | 23,761 | $8.00 | $190,088.00 |
DisclosureSEC source: 0001140361-23-000545 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848,950 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022. F2 · balance_after: A Form 4 filed by the reporting person on December 28, 2022 inadvertently overstated the total number of Common Shares held by the reporting person by 28,936 Common Shares. The updated amounts reported here correct that error and reflect the reporting person's holdings. Read SEC document |
| December 23, 2022 Filed Dec 29, 2022 02:31 UTC |
Venker EricPresident & COO
|
OtherCommon Shares | 16,031 | $7.10 | $113,820.10 |
DisclosureSEC source: 0001140361-22-047269 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901,647 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 23, 2022 Filed Dec 29, 2022 02:31 UTC |
Gline MatthewDirector · CEO
|
OtherCommon Shares | 19,408 | $7.10 | $137,796.80 |
DisclosureSEC source: 0001140361-22-047271 · form4.xml · nonDerivative · entry 1 Gline Matthew · CIK 0001750094 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125,228 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4 Read SEC document |
| December 23, 2022 Filed Dec 29, 2022 02:31 UTC |
Kumar RakhiChief Accounting Officer
|
OtherCommon Shares | 1,592 | $7.10 | $11,303.20 |
DisclosureSEC source: 0001140361-22-047270 · form4.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,178 F1 · shares: Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 09, 2022 Filed Dec 10, 2022 02:30 UTC |
Venker EricPresident & COO
|
SaleCommon Shares | 133,376 | $7.03 | $937,633.28 |
DisclosureSEC source: 0001140361-22-045162 · form4.xml · nonDerivative · entry 2 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,742 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022. Read SEC document |
| December 08, 2022 Filed Dec 10, 2022 02:30 UTC |
Venker EricPresident & COO
|
SaleCommon Shares | 11,729 | $7.00 | $82,103.00 |
DisclosureSEC source: 0001140361-22-045162 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,118 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022. Read SEC document |
| November 20, 2022 Filed Nov 22, 2022 23:30 UTC |
Venker EricPresident & COO
|
OtherCommon Shares | 16,003 | $5.00 | $80,015.00 |
DisclosureSEC source: 0001140361-22-042829 · form4.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033,847 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| November 20, 2022 Filed Nov 22, 2022 23:33 UTC |
Kumar RakhiChief Accounting Officer
|
OtherCommon Shares | 1,584 | $5.00 | $7,920.00 |
DisclosureSEC source: 0001140361-22-042831 · form4.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,770 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| November 20, 2022 Filed Nov 22, 2022 23:31 UTC |
Gline MatthewDirector · CEO
|
OtherCommon Shares | 19,373 | $5.00 | $96,865.00 |
DisclosureSEC source: 0001140361-22-042830 · form4.xml · nonDerivative · entry 1 Gline Matthew · CIK 0001750094 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,144,636 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:47 UTC |
QVT Financial LPDirector · 10% owner · Director by Deputization
|
SaleCommon Shares | 146,079 | $4.75 | $693,875.25 |
DisclosureSEC source: 0000899243-22-035818 · doc4.xml · nonDerivative · entry 6 QVT Financial LP · CIK 0001290162 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT P&E Roiv Hldgs Ltd. Disclosed balance after: 5,470,181 F2 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 122,541,536 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. F3 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Shares held by, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:47 UTC |
QVT Financial LPDirector · 10% owner · Director by Deputization
|
SaleCommon Shares | 2,311,643 | $4.75 | $10,980,304.25 |
DisclosureSEC source: 0000899243-22-035818 · doc4.xml · nonDerivative · entry 5 QVT Financial LP · CIK 0001290162 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Deferred Compensation Holdings Ltd. Disclosed balance after: 28,010,344 F2 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 122,541,536 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. F3 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Shares held by, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:47 UTC |
QVT Financial LPDirector · 10% owner · Director by Deputization
|
SaleCommon Shares | 372,427 | $4.75 | $1,769,028.25 |
DisclosureSEC source: 0000899243-22-035818 · doc4.xml · nonDerivative · entry 4 QVT Financial LP · CIK 0001290162 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Roiv Hldgs Onshore Ltd. Disclosed balance after: 13,535,929 F2 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 122,541,536 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. F4 · ownership.nature: QVT is the investment manager of QVT Roiv, shares voting and investment control over the Shares held directly by QVT Roiv and therefore may be deemed to beneficially own such Shares. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:47 UTC |
QVT Financial LPDirector · 10% owner · Director by Deputization
|
SaleCommon Shares | 1,733,577 | $4.75 | $8,234,490.75 |
DisclosureSEC source: 0000899243-22-035818 · doc4.xml · nonDerivative · entry 3 QVT Financial LP · CIK 0001290162 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Roiv Hldgs Offshore Ltd. Disclosed balance after: 37,925,362 F2 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 122,541,536 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. F4 · ownership.nature: QVT is the investment manager of QVT Roiv, shares voting and investment control over the Shares held directly by QVT Roiv and therefore may be deemed to beneficially own such Shares. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:47 UTC |
QVT Financial LPDirector · 10% owner · Director by Deputization
|
SaleCommon Shares | 1,092,355 | $4.75 | $5,188,686.25 |
DisclosureSEC source: 0000899243-22-035818 · doc4.xml · nonDerivative · entry 2 QVT Financial LP · CIK 0001290162 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 37,489,959 F2 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 122,541,536 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. F3 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Shares held by, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:44 UTC |
Gold Daniel AllenDirector
|
SaleCommon Shares | 146,079 | $4.75 | $693,875.25 |
DisclosureSEC source: 0000899243-22-035816 · doc4.xml · nonDerivative · entry 7 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT P&E Roiv Hldgs Ltd. Disclosed balance after: 5,470,181 F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F7 · ownership.nature: The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:44 UTC |
Gold Daniel AllenDirector
|
SaleCommon Shares | 2,311,643 | $4.75 | $10,980,304.25 |
DisclosureSEC source: 0000899243-22-035816 · doc4.xml · nonDerivative · entry 6 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Deferred Compensation Holdings Ltd. Disclosed balance after: 28,010,344 F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F7 · ownership.nature: The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:44 UTC |
Gold Daniel AllenDirector
|
SaleCommon Shares | 372,427 | $4.75 | $1,769,028.25 |
DisclosureSEC source: 0000899243-22-035816 · doc4.xml · nonDerivative · entry 5 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Roiv Hldgs Onshore Ltd. Disclosed balance after: 13,535,929 F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F6 · ownership.nature: QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. ("QVT Roiv"), and shares voting and investment control over the Common Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:44 UTC |
Gold Daniel AllenDirector
|
SaleCommon Shares | 1,733,577 | $4.75 | $8,234,490.75 |
DisclosureSEC source: 0000899243-22-035816 · doc4.xml · nonDerivative · entry 4 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Roiv Hldgs Offshore Ltd. Disclosed balance after: 37,925,362 F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F6 · ownership.nature: QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. ("QVT Roiv"), and shares voting and investment control over the Common Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:44 UTC |
Gold Daniel AllenDirector
|
SaleCommon Shares | 1,092,355 | $4.75 | $5,188,686.25 |
DisclosureSEC source: 0000899243-22-035816 · doc4.xml · nonDerivative · entry 3 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 37,489,959 F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:44 UTC |
Gold Daniel AllenDirector
|
GiftCommon Shares | 750,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-035816 · doc4.xml · nonDerivative · entry 2 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,142 F4 · kind: Reporting Person received these shares in the distribution described in (1) above which is exempted under 16a-13 as a change in form of beneficial ownership and subsequently gifted them to a charitable foundation, which is subject to a lock-up. F4 · price: Reporting Person received these shares in the distribution described in (1) above which is exempted under 16a-13 as a change in form of beneficial ownership and subsequently gifted them to a charitable foundation, which is subject to a lock-up. F5 · balance_after: The amount of securities owned after the reported transaction reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:43 UTC |
MANCHESTER KEITH SDirector
|
SaleCommon Shares | 146,079 | $4.75 | $693,875.25 |
DisclosureSEC source: 0000899243-22-035815 · doc4.xml · nonDerivative · entry 5 MANCHESTER KEITH S · CIK 0001244828 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT P&E Roiv Hldgs Ltd. Disclosed balance after: 5,470,181 F2 · ownership.nature: The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:43 UTC |
MANCHESTER KEITH SDirector
|
SaleCommon Shares | 2,311,643 | $4.75 | $10,980,304.25 |
DisclosureSEC source: 0000899243-22-035815 · doc4.xml · nonDerivative · entry 4 MANCHESTER KEITH S · CIK 0001244828 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Deferred Compensation Holdings Ltd. Disclosed balance after: 28,010,344 F2 · ownership.nature: The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:43 UTC |
MANCHESTER KEITH SDirector
|
SaleCommon Shares | 372,427 | $4.75 | $1,769,028.25 |
DisclosureSEC source: 0000899243-22-035815 · doc4.xml · nonDerivative · entry 3 MANCHESTER KEITH S · CIK 0001244828 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Roiv Hldgs Onshore Ltd. Disclosed balance after: 13,535,929 F2 · ownership.nature: The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:43 UTC |
MANCHESTER KEITH SDirector
|
SaleCommon Shares | 1,092,355 | $4.75 | $5,188,686.25 |
DisclosureSEC source: 0000899243-22-035815 · doc4.xml · nonDerivative · entry 2 MANCHESTER KEITH S · CIK 0001244828 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 37,489,959 F2 · ownership.nature: The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 13:40 UTC |
Dexcel Pharma Technologies Ltd.10% owner
Dexxon Holdings Ltd.10% owner
Oren Dan10% owner
|
PurchaseCommon Shares | 4,000,000 | $5.00 | $20,000,000.00 |
DisclosureSEC source: 0001104659-22-117847 · tm2230168d1_4.xml · nonDerivative · entry 1 Dexcel Pharma Technologies Ltd. · CIK 0001720007 · 10% owner Dexxon Holdings Ltd. · CIK 0001636684 · 10% owner Oren Dan · CIK 0001636701 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,849,443 F1 · shares: Dexcel Pharma Technologies Ltd. ("Dexcel") is the direct beneficial holder of 4,684,130 common shares. Dexxon Holding Ltd. ("Dexxon") is the direct beneficial holder of 98,165,313 common shares. Dan Oren is the Executive Chairman of Dexcel and the sole director of Dexxon and is ultimately the sole shareholder of each entity. F2 · price: The common shares were purchased by Dexcel in a registered public offering on November 10, 2022. Read SEC document |
| November 10, 2022 Filed Nov 16, 2022 02:00 UTC |
SVF Investments (UK) Ltd10% owner
SoftBank Vision Fund L.P.10% owner
SVF Holdings (UK) LLP10% owner
SB INVESTMENT ADVISERS (UK) LTD10% owner
|
SaleCommon Shares | 4,343,919 | $4.75 | $20,633,615.25 |
DisclosureSEC source: 0000899243-22-035945 · doc4.xml · nonDerivative · entry 1 SVF Investments (UK) Ltd · CIK 0001716729 · 10% owner SoftBank Vision Fund L.P. · CIK 0001699940 · 10% owner SVF Holdings (UK) LLP · CIK 0001716727 · 10% owner SB INVESTMENT ADVISERS (UK) LTD · CIK 0001731509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 95,031,667 F1 · ownership.nature: Securities held of record by SVF Investments (UK) Limited ("SVF Investments"). Softbank Vision Fund L.P. is the managing member of SVF Holdings (UK) LLP, which is the sole owner of SVF Investments. SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as the alternative investment fund manager ("AIFM") of SoftBank Vision Fund L.P. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund L.P.'s investments. Read SEC document |
| November 09, 2022 Filed Nov 15, 2022 02:47 UTC |
QVT Financial LPDirector · 10% owner · Director by Deputization
|
OtherCommon Shares | 1,196,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-035818 · doc4.xml · nonDerivative · entry 1 QVT Financial LP · CIK 0001290162 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 38,582,314 F1 · price: Shares were distributed in-kind to certain shareholders of QVT FIC (as defined below) who subsequently gifted the shares to charitable foundations, each of which is subject to a lock-up. F2 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 122,541,536 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT. F3 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Shares held by, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 09, 2022 Filed Nov 15, 2022 02:44 UTC |
Gold Daniel AllenDirector
|
OtherCommon Shares | 1,196,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-035816 · doc4.xml · nonDerivative · entry 1 Gold Daniel Allen · CIK 0001832142 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 38,582,314 F1 · price: Shares were distributed in-kind to certain shareholders of QVT FIC (as defined below) who subsequently gifted the shares to charitable foundations, each of which is subject to a lock-up. F2 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. Read SEC document |
| November 09, 2022 Filed Nov 15, 2022 02:43 UTC |
MANCHESTER KEITH SDirector
|
OtherCommon Shares | 1,196,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-035815 · doc4.xml · nonDerivative · entry 1 MANCHESTER KEITH S · CIK 0001244828 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd. Disclosed balance after: 38,582,314 F1 · price: Shares were distributed in-kind to certain shareholders of QVT Financial Investment Cayman Ltd. who subsequently gifted the shares to charitable foundations, each of which is subject to a lock-up. F2 · ownership.nature: The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:57 UTC |
MOMTAZEE JAMES CDirector
|
GrantCommon Shares | 3,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-039660 · form4.xml · nonDerivative · entry 1 MOMTAZEE JAMES C · CIK 0001209181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,327 F1 · shares: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. F1 · price: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 21:58 UTC |
Oren IlanDirector
|
GrantCommon Shares | 2,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-039661 · form4.xml · nonDerivative · entry 1 Oren Ilan · CIK 0001643073 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,161 F1 · shares: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. F1 · price: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.